SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rudy Saucillo who wrote (266)5/12/1997 2:14:00 PM
From: The Dermatologist   of 998
 
while ceph many be worth $6 in cash per share now, that cash is being burned. if the morons running cephalon continue to make stupid decisions (i.e., the call options mistake) why should wall street trust them in not fucking up the next NDA for Provigil?

Also, what makes you think myotrophin is going to be approved in europe. if i recall, the european trials were dog shit.

this company is toast.

i know how you feel though, i used to have faith in biotechs like magn. don't make the same mistake. the gods have smiled on you by giving you an opportunity to get out at $13. If I were you, I wouldn't look a gift horse in the mouth. I am amazed that ceph is still at this level. it won't be for long. once the volume dries up, this piece of shit is going straight down.

love,
the dermatologist
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News